(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
While acute inflammation in the body is helpful when our bodies are overcoming injury or illness, chronic inflammation is something to be warier about....